Wave Life Sciences Ltd (NASDAQ: WVE) kicked off on Tuesday, up 7.19% from the previous trading day, before settling in for the closing price of $6.12. Over the past 52 weeks, WVE has traded in a range of $4.25-$16.74.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 607.85%. While this was happening, its average annual earnings per share was recorded -37.40%. With a float of $122.54 million, this company’s outstanding shares have now reached $153.04 million.
Let’s determine the extent of company efficiency that accounts for 288 employees. In terms of profitability, gross margin is 60.69%, operating margin of -101.94%, and the pretax margin is -89.57%.
Wave Life Sciences Ltd (WVE) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Wave Life Sciences Ltd is 20.16%, while institutional ownership is 79.47%. The most recent insider transaction that took place on Mar 20 ’25, was worth 102,574. In this transaction Director of this company sold 10,500 shares at a rate of $9.77, taking the stock ownership to the 16,115 shares. Before that another transaction happened on Mar 20 ’25, when Company’s Director proposed sale 10,500 for $9.77, making the entire transaction worth $102,579.
Wave Life Sciences Ltd (WVE) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -37.40% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 0.13% during the next five years compared to 34.27% growth over the previous five years of trading.
Wave Life Sciences Ltd (NASDAQ: WVE) Trading Performance Indicators
Take a look at Wave Life Sciences Ltd’s (WVE) current performance indicators. Last quarter, stock had a quick ratio of 2.89. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 9.30.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.79, a number that is poised to hit -0.25 in the next quarter and is forecasted to reach -1.02 in one year’s time.
Technical Analysis of Wave Life Sciences Ltd (WVE)
Looking closely at Wave Life Sciences Ltd (NASDAQ: WVE), its last 5-days average volume was 1.26 million, which is a jump from its year-to-date volume of 1.16 million. As of the previous 9 days, the stock’s Stochastic %D was 66.95%. Additionally, its Average True Range was 0.68.
During the past 100 days, Wave Life Sciences Ltd’s (WVE) raw stochastic average was set at 11.53%, which indicates a significant decrease from 45.71% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 109.70% in the past 14 days, which was higher than the 75.36% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.02, while its 200-day Moving Average is $9.85. However, in the short run, Wave Life Sciences Ltd’s stock first resistance to watch stands at $6.77. Second resistance stands at $6.98. The third major resistance level sits at $7.30. If the price goes on to break the first support level at $6.24, it is likely to go to the next support level at $5.92. Now, if the price goes above the second support level, the third support stands at $5.71.
Wave Life Sciences Ltd (NASDAQ: WVE) Key Stats
The company with the Market Capitalisation of 1.01 billion has total of 153,486K Shares Outstanding. Its annual sales at the moment are 108,300 K in contrast with the sum of -97,010 K annual income. Company’s last quarter sales were recorded 83,750 K and last quarter income was 29,250 K.
